Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: A prospective study

PLoS Medicine

Volumn 8, Issue 7, 2011, Pages

  Lawn, Stephen D ^a,b   Brooks, Sophie V ^a   Kranzer, Katharina ^a,b   Nicol, Mark P ^c,d   Whitelaw, Andrew ^c,d   Vogt, Monica ^a   Bekker, Linda Gail ^a   Wood, Robin ^a,e  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; RIFAMPICIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIVIRAL THERAPY; ARTICLE; AUTOANALYSIS; BACTERIUM CULTURE; BACTERIUM EXAMINATION; CD4 LYMPHOCYTE COUNT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FEMALE; FLUORESCENCE MICROSCOPY; FLUORESCENCE SMEAR MICROSCOPY; GOLD STANDARD; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; LIQUID CULTURE; MAJOR CLINICAL STUDY; MALE; MOLECULAR DIAGNOSIS; MULTIDRUG RESISTANT TUBERCULOSIS; NONHUMAN; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; SPUTUM SMEAR; TUBERCULOSIS; XPERT MTB RIF ASSAY; ALGORITHM; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DRUG EFFECT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; MASS SCREENING; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; SOUTH AFRICA; TIME;

ADULT; ALGORITHMS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DIAGNOSTIC TECHNIQUES AND PROCEDURES; DRUG RESISTANCE, BACTERIAL; FEMALE; HIV INFECTIONS; HUMANS; MALE; MASS SCREENING; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; PROSPECTIVE STUDIES; RIFAMPIN; RISK FACTORS; SOUTH AFRICA; TIME FACTORS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 79960920501     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001067     Document Type: Article

References (37)

1. Lawn SD, Wood R, (2011) Tuberculosis in antiretroviral treatment services in resource-limited settings: addressing the challenges of screening and diagnosis. J Infect Dis In press.
2. Kranzer K, Houben RM, Glynn JR, Bekker LG, Wood R, et al. (2010) Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: a systematic review and meta-analysis. Lancet Infect Dis 10: 93-102.
3. Lawn SD, Kranzer K, Edwards DJ, McNally M, Bekker LG, et al. (2010) Tuberculosis during the first year of antiretroviral therapy in a South African cohort using an intensive pretreatment screening strategy. AIDS 24: 1323-1328.
4. Bassett IV, Wang B, Chetty S, Giddy J, Losina E, et al. (2010) Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa. Clin Infect Dis 51: 823-829.
5. Lawn SD, Myer L, Bekker LG, Wood R, (2006) Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control. AIDS 20: 1605-1612.
6. Moore D, Liechty C, Ekwaru P, Were W, Mwima G, et al. (2007) Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda. AIDS 21: 713-719.
7. Lawn SD, Harries AD, Anglaret X, Myer L, Wood R, (2008) Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 22: 1897-1908.
8. Bock NN, Jensen PA, Miller B, Nardell E, (2007) Tuberculosis infection control in resource-limited settings in the era of expanding HIV care and treatment. J Infect Dis 196 (Suppl 1): S108-S113.
9. Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, et al. (2006) Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 368: 1575-1580.
10. Wells CD, Cegielski JP, Nelson LJ, Laserson KF, Holtz TH, et al. (2007) HIV infection and multidrug-resistant tuberculosis: the perfect storm. J Infect Dis 196 (Suppl 1): S86-S107.
11. O'Donnell MR, Jarand J, Loveday M, Padayatchi N, Zelnick J, et al. (2010) High incidence of hospital admissions with multidrug-resistant and extensively drug-resistant tuberculosis among South African health care workers. Ann Intern Med 153: 516-522.
12. Reid MJ, Shah NS, (2009) Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings. Lancet Infect Dis 9: 173-184.
13. Getahun H, Kittikraisak W, Heilig CM, Corbett EL, Ayles H, et al. (2011) Development of a standardized screening rule for tuberculosis in people livign with HIV in resource-contrained settings: individual participant data meta-analysis of observational studies. PLoS Med 8: e1000391 doi:10.1371/journal.pmed.1000391.
14. World Health Organization (2010) Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings Geneva World Health Organization Available: http://whqlibdoc.who.int/publications/2011/9789241500708_eng.pdf. Accessed 7 December 2010.
15. Lawn SD, Edwards DJ, Kranzer K, Vogt M, Bekker LG, et al. (2009) Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease. AIDS 23: 1875-1880.
16. Dawson R, Masuka P, Edwards DJ, Bateman ED, Bekker LG, et al. (2010) Chest radiograph reading and recording system: evaluation for tuberculosis screening in patients with advanced HIV. Int J Tuberc Lung Dis 14: 52-58.
17. Lawn SD, Wood R, (2011) Tuberculosis screening in patients starting antiretroviral therapy: stretching diagnostics to the limits. Clin Infect Dis 52: 276-277.
18. World Health Organization (2010) Multidrug and extensively drug-resistant TB (M/XDR-TB). 2010 global report on surveillance and response. WHO/HTM/TB/2010.3 Geneva World Health Organization Available: http://whqlibdoc.who.int/publications/2010/9789241599191_eng.pdf. Accessed 18 August 2010.
19. Gandhi NR, Nunn P, Dheda K, Schaaf HS, Zignol M, et al. (2010) Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet 375: 1830-1843.
20. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, et al. (2010) Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 363: 1005-1015.
21. World Health Organization (2010) December 6 Roadmap for rolling out Xpert MTB/RIF for rapid diagnosis of TB and MDR-TB Geneva World Health Organization Available: http://www.who.int/tb/laboratory/roadmap_xpert_mtb_rif_rev23dec2010.pdf. Accessed 8 December 2010.
22. Blakemore R, Story E, Helb D, Kop J, Banada P, et al. (2010) Evaluation of the analytical performance of the Xpert(R) MTB/RIF assay. J Clin Microbiol 48: 2495-2501.
23. Helb D, Jones M, Story E, Boehme C, Wallace E, et al. (2010) Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol 48: 229-237.
24. Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, et al. (2011) Feasibility and impact of decentralised use of Xpert MTB/RIF for the diagnosis of tuberculosis and multi-drug resistance-results from a multi-center implementation study. Lancet 377: 1495-1505.
25. Armand S, Vanhuls P, Delcroix G, Courcol R, Lemaitre N, (2011) Comparison of the Xpert MTB/RIF test with an IS6110-TaqMan real-time PCR assay for direct detection of Mycobacterium tuberculosis in respiratory and nonrespiratory specimens. J Clin Microbiol 49: 1772-1776.
26. Marlowe EM, Novak-Weekley SM, Cumpio J, Sharp SE, Momeny MA, et al. (2011) Evaluation of the Cepheid Xpert MTB/RIF assay for direct detection of Mycobacterium tuberculosis complex in respiratory specimens. J Clin Microbiol 49: 1621-1623.
27. Moure R, Munoz L, Torres M, Santin M, Martin R, et al. (2011) Rapid detection of Mycobacterium tuberculosis complex and rifampin resistance in smear-negative clinical samples by use of an integrated real-time PCR method. J Clin Microbiol 49: 1137-1139.
28. Hillemann D, Rusch-Gerdes S, Boehme C, Richter E, (2011) Rapid molecular detection of extrapulmonary tuberculosis by the automated GeneXpert MTB/RIF system. J Clin Microbiol 49: 1202-1205.
29. Vadwai V, Boehme C, Nabeta P, Shetty A, Alland D, et al. (2011) Xpert MTB/RIF, a new pillar in the diagnosis of extrapulmonary tuberculosis? J Clin Microbiol E-pub ahead of print. doi:10.1128/JCM.02319-10.
30. Lawn SD, Myer L, Edwards D, Bekker LG, Wood R, (2009) Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa. AIDS 23: 1717-1725.
31. Lawn SD, Myer L, Bekker LG, Wood R, (2007) Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa. AIDS 21: 335-341.
32. South Africa Department of Health (2004) The South African National Tuberculosis Control Programme: practical guidelines Pretoria South Africa Department of Health Available: http://www.kznhealth.gov.za/chrp/documents/Guidelines/Guidelines%20National/Tuberculosis/SA%20TB%20Guidelines%202004.pdf. Accessed 15 April 2010.
33. Den Boon S, Bateman ED, Enarson DA, Borgdorff MW, Verver S, et al. (2005) Development and evaluation of a new chest radiograph reading and recording system for epidemiological surveys of tuberculosis and lung disease. Int J Tuberc Lung Dis 9: 1088-1096.
34. Lawn SD, Myer L, Orrell C, Bekker LG, Wood R, (2005) Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. AIDS 19: 2141-2148.
35. Lawn SD, Fraenzel A, Kranzer K, Caldwell J, Bekker LG, et al. (2011) Improving access to antiretroviral therapy for patients with HIV-associated tuberculosis in South Africa. S Afr Med J In press.
36. Gandhi NR, Shah NS, Andrews JR, Vella V, Moll AP, et al. (2010) HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality. Am J Respir Crit Care Med 181: 80-86.
37. Nicol M, (2010) Algorithms for referral to rapid diagnostics for MDR-TB: preliminary outcomes [presentation]. International Union Against Tuberculosis and Lung Disease 41st Union World Conference on Lung Health; November 2010; Berlin, Germany. Available: http://uwclh.conference2web.com/content/227. Accessed 2 February 2011.